Pr-20
N/A
Report date: 2025/05/14 14:16:50
Base Information
Drug NamePr-20
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEureka Therapeutics IncMemorial Sloan Kettering Cancer Center
China Registration ClassN/A
Develop Information
Active CompaniesEureka Therapeutics Inc
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A